Market Insights Health Pharmaceuticals Vaccines

COVID-19 Vaccines - Tajikistan

Tajikistan

The COVID-19 Vaccines market in Tajikistan is anticipated to witness a significant growth in revenue, with projections indicating that it will reach US$35.03m by the year 2024.
Moreover, the market is expected to exhibit a robust compound annual growth rate (CAGR) of -16.57% from 2024 to 2029, resulting in a market volume of US$14.16m by 2029.
When compared globally, it is worth noting that United States will generate the highest revenue in this market, with an estimated value of US$4,389,000.00k in 2024.
Tajikistan is prioritizing COVID-19 vaccine distribution to remote regions to ensure equitable access across the country.

Key regions: United Kingdom, Germany, France, South Korea, Italy

Market

Region

Region comparison

Currency

Analyst Opinion

Amid the global pandemic, the world is racing to develop and distribute COVID-19 vaccines. Tajikistan, a Central Asian country, is also witnessing the impact of the pandemic and its vaccination drive.

Customer preferences: As the vaccination drive is still in its early stages, customer preferences are evolving. People are becoming more aware of the importance of vaccination and are willing to get vaccinated. However, there is still some skepticism among people regarding the safety and efficacy of vaccines.

Trends in the market: The COVID-19 vaccination drive in Tajikistan started in March 2021. The country has received vaccines from different sources, including China, India, and Russia. The vaccination drive is being carried out in phases, with priority given to healthcare workers, elderly people, and people with underlying health conditions. As of now, the vaccination rate is low, and the government is working towards increasing the vaccination drive.

Local special circumstances: Tajikistan is a low-income country with a weak healthcare system. The country has a high burden of infectious diseases, including tuberculosis, malaria, and hepatitis. The government is facing challenges in managing the COVID-19 pandemic due to limited resources and infrastructure. The country has also faced criticism for its lack of transparency in reporting COVID-19 cases and deaths.

Underlying macroeconomic factors: Tajikistan's economy heavily depends on remittances from migrant workers, which have been affected due to the pandemic. The country's GDP is expected to contract in 2021 due to the pandemic's impact on various sectors such as tourism, trade, and construction. The government has taken measures to support the economy, including providing financial assistance to affected businesses and households. In conclusion, Tajikistan is facing challenges in managing the COVID-19 pandemic due to its weak healthcare system and limited resources. The vaccination drive is still in its early stages, and the government is working towards increasing the vaccination rate. The impact of the pandemic on the country's economy is significant, and the government's measures to support the economy are crucial.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.